The Mycoplasma Diagnostics Market Is Estimated To Increase At A CAGR Of 9.7 Percent During The Forecast Period 2020-2025
Mycoplasma: The term mycoplasma refers to a bacterial group that is commonly found in cell culture. The smallest self-replicating live microbe is Mycoplasma. These bacteria, also known as mollicutes, lack a cell membrane, making them resistant to penicillin antibiotics. Mycoplasma is a bacteria that can cause infections in the gastrointestinal tract. Polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), enzymatic reaction, or DNA staining are common ways to test Mycoplasma. Mycoplasma is disseminated via droplets during cell culture and can live for months in dried form. To detect Mycoplasma, polymerase chain reaction (PCR) is a frequently used technique. Market Analysis: The global Mycoplasma Diagnostics Market is expected to grow at a CAGR of 9.7% from 2020 to 2025, from a market size of USD 689 million in 2020 to USD 1,095 million in 2025. Growing worries about cell culture contamination, expansion in the pharmaceutical and biotechnology industries, and expand